RxDoctor Payments Data

Michael Kinsman, MD

Neurological Surgery · Kansas City, KSNPI 1740418235

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (39.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Medtronic at 44.2% of the total. Reporting peaked in 2022 at $4,606 and has fallen 86.0% since, to $643 in 2025.

$11,791in general payments, 2019–2025

Across 154 payments — averaging $76.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Globus Medical$3K
  • Insightec,inc$2K
  • Abbott$504
  • Nalu Medical, Inc.$221
  • Nevro Corp.$203
  • plus $707 from 7 others
$25,698in research payments, 2019–2025

Across 6 payments — averaging $4282.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Insightec,ltd$26K

What the payments were for

  • Consulting fees$1,40012%
  • Speaking & faculty fees$2,50021%
  • Grants$3563%
  • Travel & lodging$2,89625%
  • Food & beverage$4,63939%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)84$5,211
Globus Medical14$2,816
Insightec,inc7$2,128
Abbott28$504
Nalu Medical, Inc.6$221
Nevro Corp.4$203
Longeviti Neuro Solutions Inc2$195
Titan Spine, LLC1$150
Boston Scientific3$127
Stryker2$76
Johnson & Johnson1$64
Cerapedics Inc.1$58
Biotronik NRO, Inc.1$36

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,791 in reported general payments places this provider in the 80th percentile of 63 neurological surgery providers in Kansas.

See all neurological surgery providers in Kansas

Medicare billing

Part B allowed, 2024
$201,327
Medicare patients
248
Services billed
525

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib26$412
Gabapentin14$299
Oxycodone Hcl13$29

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →